TABLE 3.
Lung ultrasound findings in critically ill patients with SARS-CoV-2 pneumonia per patient#
Variable | Overall | Missing | Symptoms | Difference (95% CI) | p-value | Missing | |
≤14 days | >14 days | ||||||
BLUE per case n | 76 | 0 | 32 | 38 | 0.055 | 6 | |
A | 20 (26) | 13 (41) | 5 (13) | 28 (4–51) | |||
A/B | 16 (21) | 7 (22) | 9 (24) | −2 (−23–20) | |||
B | 11 (15) | 4 (13) | 6 (16) | −3 (−22–16) | |||
C | 29 (38) | 8 (25) | 18 (47) | −12 (−48–2) | |||
B-lines n | 51 | 25 | 21 | 24 | 0.89 | 31 | |
Total | 7±5 | 7±5 | 7±4 | ||||
PLAPS n | 68 | 8 | 27 | 37 | 0.661 | 12 | |
Present | 50 (74) | 19 (70) | 29 (78) | −8 (−33–17) | |||
Absent | 18 (26) | 8 (30) | 8 (22) | 8 (−17–33) | |||
Lung scores calculated n | 24 | 52 | 10 | 14 | 0.244 | 52 | |
LUS | 19±1 | 18±3 | 20±6 |
Data are presents as n (%) or mean±sd, unless otherwise stated. SARS-CoV-2: severe acute respiratory syndrome-coronavirus-2; BLUE: bedside lung ultrasound in emergency; PLAPS: posterolateral alveolar and/or pleural syndrome; LUS: lung ultrasound score. #: data are presented as 76 examinations in 61 patients.